tiprankstipranks
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
ONCO
Oncopeptides AB
RESEARCH TOOLSreports

Oncopeptides AB (ONCO) Stock News & Sentiment

10 Followers
Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push
Premium
Company Announcements
Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push
12d ago
Oncopeptides Raises SEK 190 Million in Partially Guaranteed Rights Issue
Premium
Company Announcements
Oncopeptides Raises SEK 190 Million in Partially Guaranteed Rights Issue
25d ago
Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany
Premium
Company Announcements
Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany
27d ago
Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma
Premium
Company Announcements
Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma
30d ago
Oncopeptides Wins Fast-Track Status for First PDC Trial in Glioblastoma
Premium
Company Announcements
Oncopeptides Wins Fast-Track Status for First PDC Trial in Glioblastoma
1M ago
Oncopeptides AB Balances Growth, Cash Crunch in Earnings
Premium
Company Announcements
Oncopeptides AB Balances Growth, Cash Crunch in Earnings
2M ago
Oncopeptides launches SEK 200m rights issue to fund Pepaxti rollout and glioblastoma push
Premium
Company Announcements
Oncopeptides launches SEK 200m rights issue to fund Pepaxti rollout and glioblastoma push
2M ago
More SE:ONCO News >

ONCO News on the Web

Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push
TipRanks News
Bullish
Oncopeptides Raises SEK 190 Million in Partially Guaranteed Rights Issue
TipRanks News
Neutral
Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany
TipRanks News
Bullish
Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma
TipRanks News
Neutral
Oncopeptides Wins Fast-Track Status for First PDC Trial in Glioblastoma
TipRanks News
Bullish
Oncopeptides AB Balances Growth, Cash Crunch in Earnings
TipRanks News
Neutral
Oncopeptides launches SEK 200m rights issue to fund Pepaxti rollout and glioblastoma push
TipRanks News
Neutral
Oncopeptides Doubles 2025 Sales and Raises Capital to Drive Glioblastoma Push
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:ONCO’s Media Buzz Sentiment?
Currently, no data Available
What is SE:ONCO’s weekly average amount of articles?
Currently, no data Available
What is SE:ONCO’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week